# Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

> **NCT00261482** · PHASE4 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 778 (actual)

## Conditions studied

- Contraception
- Female Contraception

## Interventions

- **DRUG:** norelgestromin + ethinyl estradiol

## Key facts

- **NCT ID:** NCT00261482
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 778 (ACTUAL)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261482, "Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00261482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*